Urology and GU 17/8 Flashcards
(88 cards)
metastatic prostate cancer typically spreads to:
- lymph nodes (first to the obturator nodes)
- bone
- local spread to seminal vesicles
can less commonly spread to bladder, lung, liver, brain
risk factors for prostate cancer
- increasing age
- obesity
- Afro-Caribbean ethnicity
- 5-10% of cases have a strong family history (BRCA1+2)
features of prostate cancer
- bladder outlet obstruction: hesitancy, urinary retention
- haematuria, haematospermia
- pain: back, perineal or testicular, on urination, on ejaculation
- digital rectal examination:
> asymmetrical
> hard, craggy, nodular enlargement
> loss of median sulcus
investigating prostate cancer
- PSA
- DRE
- multiparametric MRI
- transrectal ultrasound-guided biopsy
management of localised prostate cancer (T1/T2)
depends on age/life expectancy/patient choice
- active monitoring & watchful waiting
- radical prostatectomy
- radiotherapy: external beam and brachytherapy
management of localised advanced prostate cancer (T3/T4)
depends on age/life expectancy/patient choice
- radical prostatectomy
- radiotherapy: external beam and brachytherapy
- may be use for androgen therapy eg. goserelin
management of metastatic prostate cancer
- hormonal therapy (can include orchidectomy)
- chemotherapy (docetaxel)
- supportive, eg. bone protection/pain relief
- psychosocial support eg. Macmillan
LUTS
Storage:
- frequency
- urgency
- urge incontinence
- nocturia
Voiding:
- haematuria/dysuria
- hesitancy
- poor flow
- terminal dribbling
- incomplete voiding
causes of raised PSA
- benign prostatic hyperplasia (BPH)
- prostatitis
- urinary tract infection (postpone the PSA test until 1 month after treatment)
- ejaculation (ideally not in the previous 48 hours)
- vigorous exercise (ideally not in the previous 48 hours)
- urinary retention
- instrumentation of the urinary tract
management of BPH
- watchful waiting
- medication:
> first: alpha-1 antagonists eg. tamsulosin
> then: 5 alpha-reductase inhibitors eg. finasteride
surgery: transurethral resection of prostate (TURP)
mechanism of action of tamsulosin (alpha 1 antagonist)
- decrease smooth muscle tone (prostate and bladder)
- improve symptoms in around 70% of men, considered first-line
- adverse effects:
> dizziness and postural hypotension
> dry mouth
mechanism of action of finasteride (5 alpha-reductase inhibitors)
- blocks conversion of testosterone to dihydrotestosterone, which is known to induce BPH
- causes a reduction in prostate volume and may slow disease (unlike alpha-1 antagonists)
- takes time so symptoms may not improve for 6 months
- may decrease PSA concentrations by up to 50%
- adverse effects:
> erectile dysfunction
> reduced libido
> ejaculation problems
> gynaecomastia
causes of acute urinary retention
- BPH
- medications:
> anticholinergics
> tricyclic antidepressants
> NSAIDs
> opioids
> benzodiazepines - other urethral blockage, eg. stricture, calculi, cystocoele, constipation, mass
- postoperative/postpartum
- neurological
- UTI in those prone to retention
diagnosis of acute urinary retention
- catheter, send for urinalysis and culture
- bladder ultrasound (>300cm3 = diagnostic regardless of history/exam)
- measure vol from catheter, <200cm3 rules out AUR, >400cm3 means catheter should be left in
features of chronic urinary retention
- painless
- insidious
- decompression haematuria common on catheterisation
high pressure CUR:
- impaired renal function and bilateral hydronephrosis
- typically due to bladder outflow obstruction
low pressure CUR:
- normal renal function and no hydronephrosis
types of incontinence
- urge incontinence, due to detrusor hyperactivity
- stress incontinence, due to increased pressure on bladder
- mixed
- overflow incontinence, due to bladder outlet obstruction, eg. BPH
investigations for incontinence
- bladder diary (should be kept for at least 3 days)
- vaginal examination to exclude pelvic organ prolapse
- urodynamic studies
food/drug causes of haematuria appearance
foods: > beetroot > rhubarb drugs: > rifampicin > doxorubicin
criteria for an urgent 2WW referral for haematuria
Aged 45+ years AND:
- unexplained visible haematuria without urinary tract infection
OR
- visible haematuria that persists or recurs after successful treatment of urinary tract infection
Aged 60+ years AND:
- have unexplained nonvisible haematuria and either:
> dysuria
OR
> a raised white cell count on blood test
risk factors for transitional cell carcinoma
- age
- smoking
- alcohol
- exposure to aniline dyes in the printing and textile industry
- rubber manufacture
- cyclophosphamide
risk factors for squamous cell carcinoma of the bladder
- smoking
- schistosomiasis
- chronic irritation (eg. recurrent UTI/calculi)
features of bladder cancer
- painless, macroscopic haematuria
- may have LUTS
- weight loss, anaemia, etc
(mucous in urine may be a sign of adenocarcinoma)
management of bladder cancer
- superficial lesions may be managed using TURBT in isolation
- with recurrences or higher grade/risk may be offered intravesical chemotherapy
T2 staging+ offered: - surgery (radical cystectomy with ileal conduit)
- radiotherapy
types of renal calculus
- calcium oxalate (85%)
- calcium phosphate
- uric acid
- struvite
- cystine